In cellular biology, the role of reactive oxygen species (ROS) has evolved from being perceived merely as harmful metabolic ...
Immunotherapies that mobilize a patient's own immune system to fight cancer have become a treatment pillar. These therapies, ...
New York, USA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Allogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight DelveInsight’s Allogeneic ...
In a heartfelt testament to the power of family and community, Amanda Busch, an oncology pharmacist and mother of two, shared ...
Sergio A. Giralt, MD, discusses what the most commonly used conditioning regimens for patients with myelodysplastic syndrome undergoing transplants are.
A recent study evaluates the dosing, safety, and efficacy of telaglenastat and azacytidine to treat advanced myelodysplastic ...
The FDA granted galinpepimut-S a rare pediatric disease designation for the treatment of pediatric patients with acute ...
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late stage pharmaceutical company with a broad ...
Leukemia stem cells (LSCs) pose a significant challenge in treating acute myeloid leukemia (AML) due to their resistance to ...
Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback